l carnitine multiple sclerosis Dietary Supplements on Controlling Symptoms and Relapses: Current Clinical Evidence and Future Perspectives Citrullination: A Target for Disease
Description
Byle bir durumda yaklmak iin ya asitlerini tayan L-carnitini takviye etmek ie yarayabilir
Eder, J
[DOI] [PubMed] [Google Scholar] 239.Sanchez MI, Mohaidle A, Baistrocchi A, Matoso D, Vazquez H, Gonzalez A, Mazure R, Maffei E, Ferrari G, Smecuol E, Crivelli A, de Paula JA, Gomez JC, Pedreira S, Maurino E, Bai JC
The small-molecule integrin antagonist THR-687 has shown preclinical efficacy in reducing choroidal neovascularization (Hu et al., 2019) and demonstrated tolerability and anatomical benefit in early-phase trials for DME (Khanani et al., 2021)
